Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study

被引：0
|
作者：
Devos, D.
Poirot, I.
Dujardin, K.
Duhem, S.
Lucas, B.
Waucquier, N.
Moreau, C.
Bocquillon, P.
Devos, P.
Ajebbar, K.
Thielemans, B.
Cottencin, O.
Thomas, P.
Destee, A.
Bordet, R.
Defebvre, L.
机构：
来源：
MOVEMENT DISORDERS | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
727
引用
收藏
页码：S223 / S224
页数：2
相关论文
共 50 条
  • [31] A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression
    DeWilde, JE
    Geerts, S
    VanDorpe, J
    Bruhwyler, J
    Geczy, J
    ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (06) : 404 - 410
  • [32] Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
    Mizuno, Y
    Yanagisawa, N
    Kuno, S
    Yamamoto, M
    Hasegawa, K
    Origasa, H
    Kowa, H
    MOVEMENT DISORDERS, 2003, 18 (10) : 1149 - 1156
  • [33] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease
    Yokoyama, Shunichi
    Yoshinaga, Takuma
    Matsuzaki, Juntaro
    Suzuki, Hidekazu
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1187 - 1199
  • [34] A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial of Paroxetine and Venlafaxine Extended Release for Depression in Parkinson's Disease
    Richard, I. H.
    McDermott, M.
    McDonald, W. M.
    MOVEMENT DISORDERS, 2010, 25 : S680 - S680
  • [35] A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
    Payne, Thomas
    Appleby, Matthew
    Buckley, Ellen
    van Gelder, Linda M. A.
    Mullish, Benjamin H. H.
    Sassani, Matilde
    Dunning, Mark J. J.
    Hernandez, Dena
    Scholz, Sonja W. W.
    McNeill, Alisdair
    Libri, Vincenzo
    Moll, Sarah
    Marchesi, Julian R. R.
    Taylor, Rosie
    Su, Li
    Mazza, Claudia
    Jenkins, Thomas M. M.
    Foltynie, Thomas
    Bandmann, Oliver
    MOVEMENT DISORDERS, 2023, 38 (08) : 1493 - 1502
  • [36] A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
    Damier, Philippe
    Degos, Bertrand
    Castelonovo, Giovanni
    Anheim, Mathieu
    Benatru, Isabelle
    Carriere, Nicolas
    Colin, Olivier
    Defebvre, Luc
    Deverdal, Marie
    Eusebio, Alexandre
    Ferrier, Vanessa
    Giordana, Caroline
    Houeto, Jean-Luc
    Le Dily, Severine
    Mongin, Marie
    Thiriez, Claire
    Tranchant, Christine
    Ravel, Denis
    Corvol, Jean-Christophe
    Rascol, Olivier
    Ben Ari, Yehezkel
    MOVEMENT DISORDERS, 2024, 39 (03) : 618 - 622
  • [37] Efficacy and Tolerability of Advanced Glycation End-Products Inhibitor in Osteoarthritis A Randomized, Double-Blind, Placebo-controlled Study
    Garg, Shabnam
    Syngle, Ashit
    Vohra, Kanchan
    CLINICAL JOURNAL OF PAIN, 2013, 29 (08): : 717 - 724
  • [38] A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
    Jankovic, J
    Hunter, C
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (04) : 271 - 276
  • [39] The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study
    Kovacs, N.
    Nagy, F.
    Aschermann, Z.
    Pal, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 94 - 94
  • [40] The Impact of Left Prefrontal Repetitive Transcranial Magnetic Stimulation on Depression in Parkinson's Disease: a Randomized, Double-Blind, Placebo-Controlled Study
    Pal, Endre
    Nagy, Ferenc
    Aschermann, Zsuzsanna
    Balazs, Eva
    Kovacs, Norbert
    MOVEMENT DISORDERS, 2010, 25 (14) : 2311 - 2317
12345